|
US4570630A
(en)
*
|
1983-08-03 |
1986-02-18 |
Miles Laboratories, Inc. |
Medicament inhalation device
|
|
US5161524A
(en)
*
|
1991-08-02 |
1992-11-10 |
Glaxo Inc. |
Dosage inhalator with air flow velocity regulating means
|
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
|
GB9216038D0
(en)
*
|
1992-07-28 |
1992-09-09 |
Bespak Plc |
Dispensing apparatus for powdered medicaments
|
|
EP0691864A4
(en)
*
|
1993-03-03 |
1996-07-03 |
Tenax Corp |
MEDICINE CARRIER FOR DRY POWDER INHALER
|
|
US5388572A
(en)
*
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
|
US5388573A
(en)
*
|
1993-12-02 |
1995-02-14 |
Tenax Corporation |
Dry powder inhalator medicament carrier
|
|
US5505194A
(en)
*
|
1994-03-23 |
1996-04-09 |
Abbott Laboratories |
Aerosol inhalation device having slideably and rotatably connected elliptical cylinder portions
|
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
|
FR2731911B1
(fr)
*
|
1995-03-20 |
1997-08-14 |
Paul Seyvos |
Dispositif qui permet d'inhaler, par la bouche, l' odeur de produits contenus dans un reservoir a des fins therapeutiques
|
|
PT995457E
(pt)
|
1995-12-07 |
2004-07-30 |
Jago Res Ag |
Bocal para um inalador para a distribuicao reiterada doseadamente de um po farmacologicamente seco
|
|
US7131441B1
(en)
|
1995-12-07 |
2006-11-07 |
Skyepharma Ag |
Inhaler for multiple dosed administration of a pharmacological dry powder
|
|
US5669378A
(en)
*
|
1995-12-21 |
1997-09-23 |
Pera; Ivo |
Inhaling device
|
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
|
CA2212430A1
(en)
*
|
1997-08-07 |
1999-02-07 |
George Volgyesi |
Inhalation device
|
|
UA73924C2
(en)
*
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
|
DE29908593U1
(de)
|
1999-05-14 |
1999-07-22 |
Jago Research AG, Hergiswil |
Mundstück für einen Inhalator zur Abgabe eines Medikaments
|
|
HUP0300491A2
(en)
|
2000-02-28 |
2003-07-28 |
Vectura Ltd |
Improvements in or relating to the delivery of oral drugs
|
|
US6595210B2
(en)
*
|
2000-11-27 |
2003-07-22 |
Unisia Jecs Corporation |
Inhalator for administering powder composition
|
|
GB2380410B
(en)
*
|
2001-10-05 |
2003-11-19 |
Alchemy Healthcare Ltd |
Apparatus for the nasal or oral delivery of a medicament
|
|
EP1483283A4
(en)
|
2002-03-13 |
2007-04-11 |
Signum Biosciences Inc |
MODULATION OF PROTEIN METHYLATION AND PHOSPHOPROTEIN PHOSPHATE
|
|
ITMO20020297A1
(it)
*
|
2002-10-16 |
2004-04-17 |
Roberto Oliva |
Inalatore per preparati monodose in capsule.
|
|
US20060045849A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Farhan Taghizadeh |
Method of customizing the fragrance of nasal medications
|
|
PL370285A1
(pl)
*
|
2004-09-23 |
2006-04-03 |
Glaxosmithkline Pharmaceuticals Spółka Akcyjna |
Inhalator proszkowy
|
|
WO2006084033A1
(en)
|
2005-02-03 |
2006-08-10 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
|
WO2007052154A2
(en)
|
2005-04-29 |
2007-05-10 |
University Of Medicine And Dentistry Of New Jersey |
Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators
|
|
US9585932B2
(en)
|
2005-04-29 |
2017-03-07 |
Peter C. Dowling |
Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
|
|
US9345745B2
(en)
*
|
2005-04-29 |
2016-05-24 |
Bo Wang |
Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
|
|
US20070049641A1
(en)
*
|
2005-08-24 |
2007-03-01 |
Rabindra Tirouvanziam |
Methods for treating and monitoring inflammation and redox imbalance cystic fibrosis
|
|
US20090192227A1
(en)
*
|
2005-08-24 |
2009-07-30 |
Rabindra Tirouvanziam |
N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
|
|
US8227408B2
(en)
*
|
2005-09-07 |
2012-07-24 |
Neurotez, Inc. |
Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
|
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
GB0604444D0
(en)
|
2006-03-06 |
2006-04-12 |
Optinose As |
Nasal devices
|
|
AU315527S
(en)
|
2006-09-28 |
2007-08-03 |
Glaxo Group Ltd |
Inhalation device
|
|
US8741849B2
(en)
*
|
2007-01-10 |
2014-06-03 |
Purdue Research Foundation |
Kinase inhibitors and uses thereof
|
|
EP2155228B1
(en)
|
2007-01-10 |
2014-04-02 |
Purdue Research Foundation |
Polypeptide inhibitors of hsp27 kinase and uses therefor
|
|
ES2648196T3
(es)
|
2008-02-07 |
2017-12-29 |
The University Of Washington |
Dispositivo aerosol circunferencial
|
|
WO2009143380A2
(en)
*
|
2008-05-21 |
2009-11-26 |
Neurotez, Inc. |
Methods for treating progressive cognitive disorders related to neurofibrillary tangles
|
|
ES2929343T3
(es)
*
|
2008-06-13 |
2022-11-28 |
Mannkind Corp |
Inhalador de polvo seco accionado por aspiración para la administración de fármacos
|
|
DK2349310T3
(da)
*
|
2008-10-20 |
2014-08-11 |
Moerae Matrix Inc |
Polypeptid til behandling eller forebyggelse af adhæsioner
|
|
WO2010054017A1
(en)
*
|
2008-11-04 |
2010-05-14 |
Nikolaos Tezapsidis |
Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta
|
|
EP2378875B1
(en)
*
|
2008-12-10 |
2018-05-30 |
Purdue Research Foundation |
Cell-permeant peptide-based inhibitor of kinases
|
|
US8933217B2
(en)
|
2009-07-24 |
2015-01-13 |
Amazentis Sa |
Compounds, compositions, and methods for protecting brain health in neurodegenerative disorders
|
|
WO2011017132A2
(en)
*
|
2009-07-27 |
2011-02-10 |
Purdue Research, Foundation |
Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
|
|
EP4088769A1
(en)
|
2011-03-03 |
2022-11-16 |
Impel Pharmaceuticals Inc. |
Nasal drug delivery device
|
|
EP2696888B1
(en)
|
2011-04-12 |
2018-12-05 |
Moerae Matrix, Inc., |
Compositions and methods for preventing or treating pulmonary fibrosis
|
|
US9890200B2
(en)
|
2011-04-12 |
2018-02-13 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
|
EP2701712B1
(en)
|
2011-04-25 |
2017-06-21 |
Cornell University |
Use of uridine and deoxyuridine to treat folate-responsive pathologies
|
|
JP6645735B2
(ja)
|
2011-05-09 |
2020-02-14 |
インペル ニューロファーマ インコーポレイテッド |
鼻薬送達用ノズル
|
|
EP2589381B1
(en)
|
2011-11-04 |
2016-08-31 |
Rabindra Tirouvanziam |
Compositions for improving or preserving lung function in a patient with a pulmonary disorder
|
|
WO2013134636A1
(en)
|
2012-03-09 |
2013-09-12 |
Purdue Research Foundation |
Compositions and methods for delivery of kinase inhibiting peptides
|
|
CA2883703C
(en)
|
2012-09-04 |
2021-10-19 |
Eleison Pharmaceuticals, Llc |
Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
|
|
CA2909954C
(en)
|
2013-04-28 |
2021-03-23 |
Impel Neuropharma, Inc. |
Medical unit dose container
|
|
US10207065B2
(en)
|
2013-07-12 |
2019-02-19 |
John H. Silva |
Mouthpiece for inhalers
|
|
AU2014318821B2
(en)
|
2013-09-10 |
2018-04-19 |
Board Of Regents Of The University Of Texas System |
Therapeutics targeting truncated Adenomatous Polyposis Coli (APC) proteins
|
|
US10336788B2
(en)
|
2014-04-17 |
2019-07-02 |
Moerae Matrix, Inc. |
Inhibition of cardiac fibrosis in myocardial infarction
|
|
USD748242S1
(en)
|
2014-07-11 |
2016-01-26 |
H. Stuart Campbell |
Inhaler mouthpiece
|
|
US10082496B2
(en)
|
2014-09-10 |
2018-09-25 |
Board Of Regents Of The University Of Texas System |
Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
|
KR20170083063A
(ko)
|
2014-11-17 |
2017-07-17 |
모레 매트릭스 인코포레이티드 |
이상 섬유모세포 증식 및 세포외 기질 침착을 특징으로 하는 질병, 질환, 또는 과정의 예방 또는 치료용 조성물 및 방법
|
|
KR102674191B1
(ko)
|
2014-12-10 |
2024-06-11 |
하이퍼스템 에스에이 |
뇌암 줄기 세포의 성장, 이동 및 침습성 감소 그리고 뇌종양을 가진 환자의 생존 개선 방법 및 조성물
|
|
BR112017014737A2
(pt)
|
2015-01-08 |
2018-01-16 |
Moerae Matrix Inc |
formulação de peptídeos inibidores de mk2
|
|
CN107921082A
(zh)
|
2015-03-12 |
2018-04-17 |
莫伊莱麦屈克斯公司 |
含有mk2抑制剂肽的组合物用于治疗非小细胞肺癌的用途
|
|
CA2987071A1
(en)
|
2015-06-10 |
2016-12-15 |
Hackensack University Medical Center |
Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases
|
|
CN107949279A
(zh)
|
2015-07-06 |
2018-04-20 |
得克萨斯系统大学评议会 |
可用作用于治疗人类癌症的抗癌剂的苯甲酰胺或苯扎明化合物
|
|
AU2016292779B2
(en)
|
2015-07-15 |
2021-05-20 |
The Board Of Regents Of The University Of Texas System |
Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
|
MA42708A
(fr)
|
2015-09-10 |
2018-07-04 |
Impel Neuropharma Inc |
Dispositif d'administration nasale en ligne
|
|
US11833118B2
(en)
|
2016-01-20 |
2023-12-05 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
|
EP3405175A4
(en)
|
2016-01-20 |
2019-09-25 |
Flurry Powders, LLC |
Encapsulation of Lipophilic Ingredients in Dispersible Aerosol Powder Incorporated Powder
|
|
CA3081680A1
(en)
|
2017-11-21 |
2019-05-31 |
Impel Neuropharma, Inc. |
Intranasal device with inlet interface
|
|
EP3713628A4
(en)
|
2017-11-21 |
2021-08-18 |
Impel Neuropharma Inc. |
INTRA-NASAL DEVICE WITH DIVER TUBE
|
|
AU2019205329B2
(en)
|
2018-01-05 |
2023-04-20 |
Impel Pharmaceuticals Inc. |
Intranasal delivery of olanzapine by precision olfactory device
|
|
KR20200118032A
(ko)
|
2018-01-05 |
2020-10-14 |
임펠 뉴로파마 인코포레이티드 |
정밀 후각기관 장치에 의한 디하이드로에르고타민의 비강내 전달
|
|
WO2020018959A1
(en)
|
2018-07-19 |
2020-01-23 |
Impel Neuropharma, Inc. |
Respiratory tract delivery of levodopa and dopa decarboxylase inhibitor for treatment of parkinson's disease
|
|
CN113473967B
(zh)
|
2019-01-03 |
2022-09-09 |
英倍尔制药公司 |
经鼻药物递送装置
|
|
KR20220010011A
(ko)
|
2019-05-17 |
2022-01-25 |
임펠 뉴로파마 인코포레이티드 |
일회용 비강 전달 장치
|